Loading tape…Loading tape…
NTRS
NTRS
NTRS
Northern Trust was recently featured in a comparative analysis by defenseworld.net titled 'BR Biopharma (NASDAQ:BRBI) versus Northern Trust (NASDAQ:NTRS) Head to Head Survey'. The company holds a market capitalization of $34.15B alongside an annual revenue of $14.30B. Its trailing twelve-month EPS stands at 12.18, with a price-to-earnings ratio of 15.94 and a free cash flow yield of 0.38%.
Based on defenseworld.netCountdown to Northern Trust (NTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Northern Trust Gets Buy Reaffirmed Ahead Of Q3 Results, A Bet On Quality
Northern Trust Corporation (NTRS) Earnings Expected to Grow: Should You Buy?
Why Northern Trust Corporation (NTRS) is a Top Dividend Stock for Your Portfolio
Northern Trust Corporation $NTRS Shares Newly Purchased by HWG Holdings LP
UBS to Deepen NTRS Tie-Up With Credit Suisse Fund Administration Deal
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.